Login

Ben McMillan, CIO of IDX Digital Assets, discusses crypto prices in the context of ongoing macroeconomic volatility. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
4GLOBAL PLC CEO Eloy Mazon on Full-Year Results and Strategic Growth | Eloy Mazon, CEO, 4GLOBAL PLC.
00:10:00
Altice USA CEO on growth, cord-cutting, competition | Dexter Goei, CEO, Altice USA IncATUS:NYQ
00:00:00
SenzaGen presentation - Peter Nählstedt President and CEO, SenzaGen
00:10:00
supporting each funding round and bridging any gaps in between|Avidan Ross,Founding Partner,Root Ventures
00:10:00
The Bold women are always investing in bold founders|Kelly Graziadei,Founder and General Partner,f7 Ventures
00:10:00
Achieve Financial Independence with the Path to Prosperity Process
00:10:00
Genova Property Group's Interim Report Highlights for 2023 | Michael Moschewitz ,CEO , Genova Property Group AB.
00:10:00
Tapping into the collective consciousness to understand the future of our cities|Zach Aarons,Co-Founder and General Partner,MetaProp
00:10:00
Climate Change Intensifies U.S. Water Wars | Buzz Thompson - Of Counsel , O'Melveny & Myers LLP
00:10:00
Revolutionizing Retail: Aaron's New Approach to Customer Engagement and Growth|Douglas Lindsay,CEO,The Aaron’s Company, Inc.
00:10:00
Taking Action Amid Election Uncertainty
00:10:00
Venture capital and advisory firm|Hans Morris,Managing Partner,Nyca Partners

© 2017 - Neuhu+